Chemed (CHE) vs LifeStance Health Group (LFST)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
LifeStance Health Group (LFST) has outperformed Chemed (CHE) over the past year, gaining 119.0% versus a gain of 14.6%. Over five years, CHE leads with a +15.8% price change compared with +5.3% for LFST. Chemed is the larger company by market cap ($6.51 billion vs $4.58 billion), about 1.4 times the size, while LifeStance Health Group is growing revenue faster (+13.9% vs +4.1%).
On valuation, Chemed trades at a lower forward P/E (18.1x vs 28.0x for LifeStance Health Group). Chemed pays a dividend yielding 0.48%, while LifeStance Health Group does not currently pay one. Chemed converts more of its revenue into profit, with a net margin of 10.5% versus 0.7%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CHE | LFST |
|---|---|---|
| Share price | $498.25 | $12.06 |
| Market cap | $6.51B | $4.58B |
| 1-day change | -0.64% | -0.41% |
| YTD return | +16.45% | +72.02% |
| 1-year return | +14.55% | +118.99% |
| 5-year return | +15.84% | +5.30% |
| P/E ratio (TTM) | 25.06 | 92.77 |
| Forward P/E | 18.11 | 28.00 |
| EPS (TTM) | $19.88 | $0.13 |
| Dividend yield | 0.48% | 0.00% |
| Annual dividend | $2.40 | $0.00 |
| Revenue (latest FY) | $2.53B | $1.42B |
| Revenue growth (YoY) | +4.06% | +13.85% |
| Net income (latest FY) | $265.24M | $9.66M |
| Gross margin | 32.54% | — |
| Operating margin | 13.37% | 1.70% |
| Net margin | 10.48% | 0.68% |
| 52-week high | $557.00 | $13.56 |
| 52-week low | $365.21 | $4.77 |
| Distance from 52-week high | -10.55% | -11.06% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +14.72% | +19.40% |
| Average volume | 159.85K | 4.35M |
| Shares outstanding | 13.07M | 380.15M |
| Employees | 15,811 | 8,542 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LFST has outperformed CHE by 104.4 percentage points over the past year.
- LifeStance Health Group trades at a higher earnings multiple (92.8x vs 25.1x trailing P/E).
- Chemed is more profitable, keeping 10.5 cents of every revenue dollar as net income versus 0.7 cents for LifeStance Health Group.
- LifeStance Health Group grew revenue faster in its latest fiscal year (+13.85% vs +4.06%).
About Chemed
CHE stock →Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments.
Health Care · Medical/Nursing Services · 15,811 employees
About LifeStance Health Group
LFST stock →LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services, psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
Health Care · Medical/Nursing Services · 8,542 employees
CHE vs LFST FAQ
Which is bigger, Chemed or LifeStance Health Group?
Chemed (CHE) is larger, with a market capitalization of $6.51B compared with $4.58B for LifeStance Health Group (LFST).
Which stock has performed better over the past year, CHE or LFST?
LFST returned +118.99% over the past 12 months, compared with +14.55% for CHE (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CHE or LFST?
CHE has the lower trailing P/E at 25.1, versus 92.8 for LFST. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Chemed or LifeStance Health Group?
Chemed pays a dividend yielding 0.48%, while LifeStance Health Group does not currently pay a regular dividend.
Are Chemed and LifeStance Health Group in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.